NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Tomosynthesis as Primary Test for Breast Cancer Screening

Active Not RecruitingNA

Sponsor: Azienda USL Reggio Emilia - IRCCS

Conditions: Breast Cancer

Interventions: tomosynthesis + synthetic 2D, digital mammography

Countries: Italy

Randomized trial comparing tomosynthesis plus synthetic 2D Mammography vs Digital Mammography in respect to incidence of advanced cancers (interval and following round) and interval cancers.

Eligibility overview

Sex: FEMALE

Age: 45 Years to 65 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Women scheduled for a new round of mammographic screening
* resident in the province

Exclusion Criteria:

* previous breast cancer diagnosis
* pregnancy or suspicion of pregnancy
* presence of BRCA1/2 gene mutation
* Previous Digital Breast Tomosynthesis performed
* unable to understand informed consent
* chemotherapy in progress
* presence of breast implant

Locations (4)

Reggio Emilia, Italy, Italy
Milan, Italy
Verona, Italy
Verona, Italy